What does GUERRERO MED. do?

GUERRERO MED. is a specialist medical practice in Gembloux. Private Limited, started on 1 March 2012, 1 establishment.

What is the address of GUERRERO MED.?

The registered office of GUERRERO MED. is located at Rue du Moulin 65 box 8, 5030 Gembloux.

Is GUERRERO MED. still active?

Yes. According to the CBE (28 September 2026) GUERRERO MED. is active, legal situation “Normale toestand”, started on 1 March 2012.

Is GUERRERO MED. registered on Peppol?

Yes, GUERRERO MED. is registered on the Peppol network with ID 0208:0844094889.

What is the enterprise number of GUERRERO MED.?

The enterprise number of GUERRERO MED. is BE0844094889.

When was GUERRERO MED. founded?

GUERRERO MED. was founded on 1 March 2012.

Who are the directors of GUERRERO MED.?

According to the 2025 annual accounts, the directors of GUERRERO MED. are: Cristina Guerrero Lopez.

Is GUERRERO MED. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 March 2012; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GUERRERO MED. make in 2025?

GUERRERO MED. posted a profit after taxes of € 68,471 in financial year 2025.

What is the revenue of GUERRERO MED.?

As a small company, GUERRERO MED. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 110,154.

GUERRERO MED. (Private Limited) - Gembloux - BE0844094889

Dossier GUERRERO MED., printed on 28 September 2026 from databakkes.be/en/0844094889/guerrero-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GUERRERO MED. from Gembloux, company number BE0844094889, closed financial year 2025 with a result of € 68,471 after tax. For that financial year GUERRERO MED. recorded a gross margin of € 110,154 and equity of € 147,334. Compared with financial year 2024, the result moved from € 54,190 to € 68,471. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 24, 2026.

What it is worth Growing

€ 147,334

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 68,471

▲ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 123,520

▲ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 68,193 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 9,799

▼ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 230

▼ 49% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 29,699

▲ 14% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 27,044 Gross margin 2022: € 27,044 First fiscal year in the series	€ 77,316 Gross margin 2023: € 77,316 ▲ 186% vs 2022 (€ 27,044) Favourable step	€ 87,682 Gross margin 2024: € 87,682 ▲ 13% vs 2023 (€ 77,316) Favourable step	€ 110,154 Gross margin 2025: € 110,154 ▲ 26% vs 2024 (€ 87,682) Favourable step	▲ 26%
Profit after taxes	€ 8,519 Profit after taxes 2022: € 8,519 First fiscal year in the series	€ 47,556 Profit after taxes 2023: € 47,556 ▲ € 39,037 vs 2022 (€ 8,519) Favourable step	€ 54,190 Profit after taxes 2024: € 54,190 ▲ 14% vs 2023 (€ 47,556) Favourable step	€ 68,471 Profit after taxes 2025: € 68,471 ▲ 26% vs 2024 (€ 54,190) Favourable step	▲ 26%
Equity	€ 94,918 Equity 2022: € 94,918 First fiscal year in the series	€ 112,866 Equity 2023: € 112,866 ▲ 19% vs 2022 (€ 94,918) Favourable step	€ 147,056 Equity 2024: € 147,056 ▲ 30% vs 2023 (€ 112,866) Favourable step	€ 147,334 Equity 2025: € 147,334 Unchanged (€ 147,056) Favourable step
Total debts	€ 41,354 Total debts 2022: € 41,354 First fiscal year in the series	€ 34,108 Total debts 2023: € 34,108 ▼ 18% vs 2022 (€ 41,354) Favourable step	€ 40,544 Total debts 2024: € 40,544 ▲ 19% vs 2023 (€ 34,108) Unfavourable step	€ 94,215 Total debts 2025: € 94,215 ▲ 132% vs 2024 (€ 40,544) Unfavourable step	▲ 132%
Cash	€ 54,109 Cash 2022: € 54,109 First fiscal year in the series	€ 68,975 Cash 2023: € 68,975 ▲ 27% vs 2022 (€ 54,109) Favourable step	€ 102,175 Cash 2024: € 102,175 ▲ 48% vs 2023 (€ 68,975) Favourable step	€ 123,520 Cash 2025: € 123,520 ▲ 21% vs 2024 (€ 102,175) Favourable step	▲ 21%
Retained profit	€ 82,518 Retained profit 2022: € 82,518 First fiscal year in the series	€ 100,466 Retained profit 2023: € 100,466 ▲ 22% vs 2022 (€ 82,518) Favourable step	€ 134,656 Retained profit 2024: € 134,656 ▲ 34% vs 2023 (€ 100,466) Favourable step	€ 134,934 Retained profit 2025: € 134,934 Unchanged (€ 134,656) Favourable step
Dividend	€ 22,358 Dividend 2022: € 22,358 First fiscal year in the series	€ 29,608 Dividend 2023: € 29,608 ▲ 32% vs 2022 (€ 22,358) Unchanged	€ 20,000 Dividend 2024: € 20,000 ▼ 32% vs 2023 (€ 29,608) Unchanged	€ 68,193 Dividend 2025: € 68,193 ▲ 241% vs 2024 (€ 20,000) Unchanged	▲ 241%
Bank debt	€ 11,250 Bank debt 2022: € 11,250 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 11,250) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 136,272 Balance sheet total 2022: € 136,272 First fiscal year in the series	€ 146,974 Balance sheet total 2023: € 146,974 ▲ 8% vs 2022 (€ 136,272) Unchanged	€ 187,599 Balance sheet total 2024: € 187,599 ▲ 28% vs 2023 (€ 146,974) Unchanged	€ 241,550 Balance sheet total 2025: € 241,550 ▲ 29% vs 2024 (€ 187,599) Unchanged	▲ 29%

Key figures of GUERRERO MED., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to GUERRERO MED.?

What happened at GUERRERO MED. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 24, 2026 New annual accounts for financial year 2025: profit of € 68,471 (▲ 26% vs 2024). filed late Source: NBB ↗
Mar 1, 2012 New establishment in Gembloux. KBO
Mar 1, 2012 Start of the company according to the CBE. KBO
2011 Cristina Guerrero Lopez became a director. NBB

In short

From € 8,519 profit in 2022 to € 68,471 profit in 2025.

Paid € 67,732 in corporate taxes since 2022.

Best year ever: 2025, with € 68,471 profit.

Paid out € 140,159 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at GUERRERO MED.? We notify you, reason included.

Follow GUERRERO MED.

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Cristina Guerrero Lopez

GUERRERO MED.

Behind GUERRERO MED. is Cristina Guerrero Lopez.

See the full network in the app

Directors

According to the 2025 annual accounts

Cristina Guerrero Lopez

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Moulin 65 box 8

5030 Gembloux

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0844.094.889
VAT number: BE 0844.094.889
Registered office: Rue du Moulin 65 bus 8, 5030 Gembloux
Names & denominations: GUERRERO MED.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 March 2012
Peppol: Active · Active since 31 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗